A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study

Clinical trial NCT07661329 · RECRUITING

Trial details

NCT number: NCT07661329
Sponsor: YS Life Science Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OH)

Start date: 2026-06-02
Primary completion: 2027-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.